Cargando…

Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes

BACKGROUND: The role of immune checkpoint inhibitors in endometrial cancer is limited. At present, the anti-programmed cell death protein 1 (anti-PD-1) antibody is only used in patients with recurrence or metastasis. CD40 is an important immune checkpoint, which is expressed in tumor cells and immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Na, Sun, Bowen, Cheng, Yuan, Wang, Jianliu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317534/ https://www.ncbi.nlm.nih.gov/pubmed/37404251 http://dx.doi.org/10.2147/TCRM.S416220

Ejemplares similares

Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer
por: Zhai, Lirong, et al.
Publicado: (2023)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
por: Yang, Xiao, et al.
Publicado: (2021)

Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
por: Li, Xingchen, et al.
Publicado: (2023)

Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
por: Dai, Yibo, et al.
Publicado: (2019)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

CD40/CD40L expression and its prognostic value in cervical cancer
por: Grazia, G.A., et al.
Publicado: (2023)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: Analysis of The Cancer Genome Atlas data
por: He, Xiangjun, et al.
Publicado: (2020)

Relationship between Hypothyroidism and Endometrial Cancer
por: Wang, Yiqin, et al.
Publicado: (2019)

The Role of Metabolic Syndrome in Endometrial Cancer: A Review
por: Yang, Xiao, et al.
Publicado: (2019)

Calcium-Related Genes Predicting Outcomes and Serving as Therapeutic Targets in Endometrial Cancer
por: Huang, Ting, et al.
Publicado: (2022)

The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels
por: Liu, Zuo-Liang, et al.
Publicado: (2018)

Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis
por: Cheng, Yuan, et al.
Publicado: (2020)

Association Between Abdominal Adipose Tissue Distribution and Risk of Endometrial Cancer: A Case-Control Study
por: Cheng, Yuan, et al.
Publicado: (2022)

Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients
por: Fan, Yuan, et al.
Publicado: (2021)

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
por: Voss, M A, et al.
Publicado: (2011)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
por: Fan, Yuan, et al.
Publicado: (2021)

Tumor Heterogeneity at Protein Level as an Independent Prognostic Factor in Endometrial Cancer()
por: Supernat, Anna, et al.
Publicado: (2014)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2021)

Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
por: Cheng, Yuan, et al.
Publicado: (2021)

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention
por: Huang, Ting, et al.
Publicado: (2022)

Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2020)

The prognostic value of CD44 isoform expression in endometrial cancer.
por: Tempfer, C., et al.
Publicado: (1998)

Prognostic impact of CD133 expression in Endometrial Cancer Patients
por: Mancebo, G., et al.
Publicado: (2017)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
por: Allott, Emma H., et al.
Publicado: (2016)

Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
por: Evrard, Camille, et al.
Publicado: (2019)

CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022)

Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review
por: Zhai, Lirong, et al.
Publicado: (2021)

Ykl-40 and cancer antigen 72-4 as new and promising diagnostic and prognostic markers for endometrial cancer
por: Karataş, Suat, et al.
Publicado: (2018)

A detailed analysis of lymph node recurrence in endometrial carcinoma
por: Li, He, et al.
Publicado: (2022)

ATX-LPA axis facilitates estrogen-induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway
por: Zhang, Guo, et al.
Publicado: (2018)

An elevated preoperative serum calcium level is a significant predictor for positive peritoneal cytology in endometrial carcinoma
por: Li, Xingchen, et al.
Publicado: (2019)

Requirement for CD40/CD40L Interactions for Development of Autoimmunity Differs Depending on Specific Checkpoint and Costimulatory Pathways
por: Voynova, Elisaveta, et al.
Publicado: (2018)

Maintenance Therapy Can Improve the Oncologic Prognosis and Obstetrical Outcome of Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer After Fertility-Preserving Treatment: A Multicenter Retrospective Study
por: He, Yijiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rp1aajugq6ral0ju5mc5da3rfj